PROGNOSTIC VALUE OF NON-HIGH-DENSITY CHOLESTEROL FOR CARDIOVASCULAR OUTCOMES IN PATIENTS WITH NON-ST ELEVATION ACUTE CORONARY SYNDROME

Nguyễn Phương Hải Trần, Văn Sỹ Hoàng

Main Article Content

Abstract

Background: Many analyses have demonstrated the role of non-HDL-C in evaluating cardiovascular disease due to atherosclerosis. Non-HDL-C levels also have a prognostic role for long-term cardiovascular outcomes in patients who have experienced a cardiac event. However, data on the prognostic role of non-HDL-C in cardiovascular outcomes in Vietnam are limited. Objectives: To describe the non-HDL-C concentration characteristics in patients with acute coronary syndrome and evaluate the predictive role of non-HDL-C for long-term cardiovascular outcomes. Materials: We conducted a cross-sectional study with longitudinal follow-up in 220 patients diagnosed with acute coronary syndrome admitted to Cho Ray Hospital. Methods: Descriptive cross-sectional study with longitudinal follow-up. Results: Of the 220 patients included in the study, the mean age was 65.5 ± 11.0 years, and 59.1% were male. The mean non-HDL-C concentration was 146.5 ± 48.7 mg/dL. The percentage of patients with non-HDL-C < 85 mg/dL and < 100 mg/dL was 9.5% and 14.5%, respectively. After 30 months of follow-up, 9.1% of patients died from any cause. The non-HDL-C concentration was able to predict the 30-month mortality outcome with an area under the curve of 0.64 (95% confidence interval: 0.57 – 0.70). At the non-HDL-C cut-off point of 159 mg/dL, the sensitivity was 90%, and the specificity was 36.5% for predicting all-cause mortality. Conclusions: Our study showed that patients with non-ST-elevation acute coronary syndrome had a low rate of achieving the non-HDL-C target. Non-HDL-C concentration was able to predict all-cause mortality at the 30-month time point.

Article Details

References

1. Tsao CW, Aday AW, Almarzooq ZI, et al. Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association. Circulation. 2023 Feb 21;147(8):e93-e621. doi:10.1161/cir.0000000000001123
2. An International Atherosclerosis Society Position Paper: global recommendations for the management of dyslipidemia--full report. J Clin Lipidol. 2014 Jan-Feb;8(1):29-60. doi:10.1016/j.jacl.2013.12.005
3. Harari G, Green MS, Magid A, Zelber-Sagi S. Usefulness of Non-High-Density Lipoprotein Cholesterol as a Predictor of Cardiovascular Disease Mortality in Men in 22-Year Follow-Up. Am J Cardiol. 2017 Apr 15;119(8):1193-1198. doi:10.1016/j.amjcard.2017.01.008
4. Cui Y, Blumenthal RS, Flaws JA, et al. Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med. 2001 Jun 11;161(11):1413-9. doi:10.1001/archinte.161.11.1413
5. Wongcharoen W, Sutthiwutthichai S, Gunaparn S, Phrommintikul A. Is non-HDL-cholesterol a better predictor of long-term outcome in patients after acute myocardial infarction compared to LDL-cholesterol? : a retrospective study. BMC Cardiovasc Disord. 2017 Jan 5;17(1):10. doi:10.1186/s12872-016-0450-9
6. Roffi M, Patrono C, Collet JP, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016 Jan 14;37(3):267-315. doi:10.1093/eurheartj/ehv320
7. Aggarwal DJ, Kathariya MG, Verma DPK. LDL-C, NON-HDL-C and APO-B for cardiovascular risk assessment: Looking for the ideal marker. Indian Heart J. 2021 Sep-Oct;73(5):544-548. doi:10.1016/j.ihj.2021.07.013
8. Su X, Luo M, Tang X, Luo Y, Zheng X, Peng D. Goals of non-high density lipoprotein cholesterol need to be adjusted in Chinese acute coronary syndrome patients: Findings from the CCC-ACS project. Clin Chim Acta. 2019 Sep;496:48-54. doi:10.1016/j.cca.2019.06.022